LILRB4 and neoplasm: In a recent study it was shown that LILRB4 interactions with fibronectin are capable of polarizing or maintaining DCs in the TME and draining lymph nodes in an immunosuppressive state, ultimately leading to decreased T cell activation and anti-tumor activity (89).